Characterization of MGCs in LCH lesions for osteoclast markers, osteoclast-secreted enzymes, and osteoclast-inducing environment
. | MGCs in lesion . | . | . | . | . | . | Lesional environment . | . | . | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | Phenotypic markers of osteoclasts . | . | . | Osteoclast-secreting enzymes . | . | Osteoclast-inducing cytokines and receptor . | . | . | |||||||
Lesional site . | CD1a . | CD68 . | TRAP . | VNR . | CatK . | MMP-9 . | M-CSF . | RANKL . | RANK . | |||||||
Bone | ||||||||||||||||
b1 | – | ++ | ++ | ++ | ++ | ++ | # | # | # | |||||||
b2 | – | ++ | – | ++ | ++ | ++ | – | # | # | |||||||
b3 | – | – | – | – | – | – | # | # | # | |||||||
b4 | – | + | – | + | + | + | # | # | # | |||||||
b5 | – | ++ | ++ | ++ | + | ++ | – | # | # | |||||||
b6 | – | +++ | +++ | +++ | + | ++ | # | # | # | |||||||
b7 | – | ++ | ++ | ++ | ++ | ++ | # | – | # | |||||||
b8 | – | – | – | – | – | – | # | # | # | |||||||
b9 | – | ++ | – | + | + | ++ | # | – | # | |||||||
b10 | – | ++ | ++ | + | + | ++ | # | – | # | |||||||
b11 | – | + | + | + | + | + | # | # | # | |||||||
b12 | – | +++ | +++ | +++ | +++ | +++ | # | – | # | |||||||
b13 | – | ++ | – | + | + | ++ | – | # | # | |||||||
b14 | – | +++ | +++ | ++ | ++ | ++ | # | # | # | |||||||
b15 | – | + | + | + | + | +++ | – | # | # | |||||||
Skin | ||||||||||||||||
s1 | ++ | ++ | ++ | ++ | ++ | + | # | # | # | |||||||
s2 | – | – | – | – | – | – | # | – | # | |||||||
s3 | – | – | – | – | – | – | ND | – | # | |||||||
s4 | – | – | – | – | – | – | ND | ND | – | |||||||
s5 | – | + | + | – | – | – | ND | ND | ND | |||||||
s6 | – | + | – | – | – | – | – | # | # | |||||||
s7 | – | – | – | – | – | – | – | – | – | |||||||
Lymph node | ||||||||||||||||
l1 | ++ | ++ | ++ | ++ | ++ | ++ | # | # | ND | |||||||
l2 | ND | + | + | + | + | + | # | # | # | |||||||
l3 | – | +++ | – | +++ | +++ | +++ | # | # | # | |||||||
l4 | + | + | + | + | + | + | – | # | # |
. | MGCs in lesion . | . | . | . | . | . | Lesional environment . | . | . | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | Phenotypic markers of osteoclasts . | . | . | Osteoclast-secreting enzymes . | . | Osteoclast-inducing cytokines and receptor . | . | . | |||||||
Lesional site . | CD1a . | CD68 . | TRAP . | VNR . | CatK . | MMP-9 . | M-CSF . | RANKL . | RANK . | |||||||
Bone | ||||||||||||||||
b1 | – | ++ | ++ | ++ | ++ | ++ | # | # | # | |||||||
b2 | – | ++ | – | ++ | ++ | ++ | – | # | # | |||||||
b3 | – | – | – | – | – | – | # | # | # | |||||||
b4 | – | + | – | + | + | + | # | # | # | |||||||
b5 | – | ++ | ++ | ++ | + | ++ | – | # | # | |||||||
b6 | – | +++ | +++ | +++ | + | ++ | # | # | # | |||||||
b7 | – | ++ | ++ | ++ | ++ | ++ | # | – | # | |||||||
b8 | – | – | – | – | – | – | # | # | # | |||||||
b9 | – | ++ | – | + | + | ++ | # | – | # | |||||||
b10 | – | ++ | ++ | + | + | ++ | # | – | # | |||||||
b11 | – | + | + | + | + | + | # | # | # | |||||||
b12 | – | +++ | +++ | +++ | +++ | +++ | # | – | # | |||||||
b13 | – | ++ | – | + | + | ++ | – | # | # | |||||||
b14 | – | +++ | +++ | ++ | ++ | ++ | # | # | # | |||||||
b15 | – | + | + | + | + | +++ | – | # | # | |||||||
Skin | ||||||||||||||||
s1 | ++ | ++ | ++ | ++ | ++ | + | # | # | # | |||||||
s2 | – | – | – | – | – | – | # | – | # | |||||||
s3 | – | – | – | – | – | – | ND | – | # | |||||||
s4 | – | – | – | – | – | – | ND | ND | – | |||||||
s5 | – | + | + | – | – | – | ND | ND | ND | |||||||
s6 | – | + | – | – | – | – | – | # | # | |||||||
s7 | – | – | – | – | – | – | – | – | – | |||||||
Lymph node | ||||||||||||||||
l1 | ++ | ++ | ++ | ++ | ++ | ++ | # | # | ND | |||||||
l2 | ND | + | + | + | + | + | # | # | # | |||||||
l3 | – | +++ | – | +++ | +++ | +++ | # | # | # | |||||||
l4 | + | + | + | + | + | + | – | # | # |
–, absence of expression; #, expression; +, 0–30% expression by the MGCs; ++, 30–70% expression by the MGCs; +++, 70–100% expression by the MGCs; ND, not determined due to lack of tissue.